1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Iran Hepatitis Network: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian Patients Sofosbuvir/Ledipasvir 12W, Sofosbuvir/Ledipasvir plus Ribavirin 12W, Sofosbuvir/Ledipasvir 24W - Hepatitis C | Phase 3 | Unknown | Iran Hepatitis Network | 200 | 2017-03-01 | 2017-02-23 |
Hepatitis C (1)
Sofosbuvir (1) · ledipasvir (1)
Bita Behnava, MD (1) · Heidar Sharafi, PhD (1) · Mohammad Saeid Rezaee-Zavareh, MD (1) · Seyed Moayed Alavian, MD (1)